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Abstract
Aims—To present data obtained from
human bone marrow preparations from
healthy individuals showing that the
proportion of metaphases with silver
stained nucleolar organiser region
(AgNOR) chromosomes is associated with
the age of the donor.
Methods—Bone marrow preparations
from eight Russian and 10 Argentinian
healthy individuals donating bonemarrow
for heterologous transplantation were
studied by silver staining. The Russian
bone marrow preparations were used
directly, while the bone marrow speci-
mens from Argentinian donors were incu-
bated for 24 hours at 37°C in F-10 medium
with 15% fetal bovine serum. The slides
were silver stained by the one step method
of Howell and Black with slight modifica-
tions. Thirty metaphases with clearly
defined D and G group chromosomes
were scored for the numbers of AgNORs.
All metaphases that were adjacent to
silver stained interphase nuclei were ana-
lysed to assess the percentage of AgNOR
positive mitoses. The Kruskal Wallis test
and Kendall’s rank correlation coeYcient
(rK) were used to assess the relation
between age and the percentage of AgNOR
positive cells.
Results—The mean numbers (SE) of
AgNORs per metaphase were 5.06 (0.17)
and 5.56 (0.23) for the Russian and Argen-
tinian groups, respectively, with no sig-
nificant diVerences between the two
groups. The common percentage of
AgNOR positive cells decreased signifi-
cantly as a function of age, with an
rK = −0.57 (p < 0.0012).
Conclusions—The percentages of AgNOR
negative metaphases in bone marrow
from healthy individuals is strongly asso-
ciated with age and this may be related to
age related telomere loss.
(J Clin Pathol:Mol Pathol 1998;51:39–42)
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A cytochemical silver nitrate technique can be
used eVectively to monitor the activity of ribos-
omal RNA cistrons because a subset of nucleo-
lar argentophilic proteins are associated with
transcriptionally active rDNA.1 According to
recent findings, the proteins responsible for
nucleolar organiser regions silver staining
(AgNORs) on metaphase chromosomes in-
clude RNA polymerase I, topoisomerase IIÆ,
transcription factor UBF, and probably
nucleolin.2 Studies on the AgNOR staining
pattern in bone marrow cells from donors and
patients with haematological malignancies
have revealed significant decreases of modal
AgNOR classes as well as a high percentage of
AgNOR negative mitoses (mean, 48%; range,
34–70%) compared with PHA stimulated lym-
phocytes from the same subjects.3–13 On the
basis of these data, a hypothesis was put
forward which related the AgNOR negative
mitoses in bone marrows from healthy indi-
viduals and patients with leukaemias to poly-
chromatic normoblasts and myelocytes, whose
activity with regard to the synthesis of rRNA
was clearly decreased.4–6 12 14 This hypothesis
has been verified by analysing the pattern of
AgNOR staining in interphase nuclei of bone
marrow erythroid and granulocytic elements of
various maturities obtained from healthy do-
nors and patients with leukaemias.2 5–7 12 14–18
Recently, Pedrazzini and Slavutsky noted
that the AgNOR pattern of normal bone mar-
row cells is age related, but that this phenom-
enon is not seen in patients with mycosis
fungoides13 and acute lymphoblastic leukaemia
(unpublished data). Additional analysis of our
previously published data5 also supported this
conclusion.
Materials and methods
Bone marrow samples were obtained from
eight Russian5 and 10 Argentinian healthy
individuals donating bone marrow for heter-
ologous transplantation (table 1).
The Russian bone marrow preparations were
made from aspirates of the sternum, fixed in
3:1 methanol:acetic acid for 10 minutes, and
air dried smeared.5 Bone marrow samples from
Argentinian donors were incubated for 24
hours at 37°C in F-10 medium with 15% fetal
bovine serum. Colcemid (final concentration
0.1 µg/ml) was added 40 minutes before
harvesting. Cells were incubated in 0.075 M
KCl for 20 minutes at 37°C, pelleted, and fixed
in methanol:glacial acetic acid (3:1). After the
cells had been washed three times in the
fixative, air dried slides were prepared. In both
cases, the slides were stained with the one step
method of Howell and Black19 that uses
gelatine as the silver colloidal protector and
pretreatment in 2 M formic acid for 10
minutes to improve the evaluation of AgNORs
in bone marrow cells. A total of 30 metaphases
with clearly defined D and G group chromo-
somes were scored for the mean number of
AgNORs. All metaphases that were adjacent to
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silver stained interphase nuclei were analysed
to assess the percentages of AgNOR positive
mitoses.
Because the data for the bone marrow sam-
ples were not distributed normally, we used the
Kruskal-Wallis test to compare groups and the
Kendall’s rank correlation coeYcient (rK) for
the relation between age and the percentage of
AgNOR positive cells.
Results
Results from the silver staining of normal bone
marrow cells are summarised in table 1.
Among the 10 potentially stainable chromo-
somes the mean (SE) numbers of AgNORs per
metaphase were 5.06 (0.17) and 5.56 (0.23)
for the Russian and Argentian groups, respec-
tively. There were no significant diVerences
between the two groups, with a mean (SE) of
5.34 (0.15) AgNOR chromosomes per bone
marrow cell when the two groups were
analysed together. As regards the proportion of
mitoses demonstrating silver staining on at
least one chromosome, when the two groups
were analysed together the mean (SE) was
55.1% (3.7%); when the two groups were ana-
lysed separately, the results were 65.6% (4.5%)
and 46.8% (5.7%) for the Russian and Argen-
tinian groups, respectively, with a significant
diVerence between them (p < 0.04). Upon
analysis, it was apparent that each group had a
diVerent mean age (p < 0.01); accordingly, we
examined the relation between the percentage
of AgNOR positive mitoses and the age of the
bone marrow donors. We found that the
percentage of AgNOR positive cells decreased
significantly in function with age, with an
rK = −0.57 (p < 0.0012) (fig 1).
Discussion
The above results show that the percentage of
AgNOR negative metaphases in bone marrow
from healthy individuals is associated strongly
with age. In relation to these findings, it must
be remembered that AgNOR negative mitoses
in normal bone marrow are mainly present in
erythroid and granulocytic elements. The latter
finding has been shown by us in patients with
multiple myeloma, where all mitoses of dis-
eased cells (with chromosome markers) were
AgNOR positive, whereas the majority of
AgNOR negative mitoses were in cells with a
normal karyotype.6
As discussed, the technical approaches used
by the two laboratories participating in this
study were not identical. Nevertheless, similar
data were obtained, although the more active
erythroid precursors appear to be the main
mitotic cells in the bone marrow preparations
from the Russian donors. On the other hand,
the great majority of mitoses from the short
term bone marrow cultures of the Argentinian
controls are of granulocytic origin because cul-
tured erythroid cells cannot grow eVectively
without the addition of erythropoietin. Accord-
ingly, it is not surprising, that the mean number
(SE) of AgNOR positive metaphases in the
Russian samples was significantly higher than
that found in the Argentinian samples (65.6%
(4.5%) and 46.8% (7%), respectively;
p < 0.04). These findings are in agreement
with earlier published data related to age
dependent decreases in the numbers of Ag-
NORs in PHA stimulated human
lymphocytes.20–23 The relevant investigators
related these findings to either a progressive
decrease of lymphocyte proliferative
activity,21 24 or a hypothetical progressive inacti-
vation of rRNA genes with aging.20 22 Also,
there is little evidence of an expected age
related decrease in proliferative activity of
erythroid and granulocytic precursors.25 26
Meanwhile, there is increasing evidence that
anaemia and leucocyte abnormalities in other-
wise healthy elderly patients are not a normal
physiological consequence of aging, but rather
result from multiple insults and increased hae-
mopoietic demands.26
In the light of these controversial ideas it
seems that there may be a relation between the
number of AgNORs in interphase nuclei and
their indices of proliferative activity. This
evidence is indirect, despite the fact that
nucleolar argentophilic proteins such as RNA
polymerase I, topoisomerase IIÆ, transcription
factor UBF, and nucleolin2 can be good mark-
ers of cell proliferation. It is likely that cells
need rDNA expression, ribosome formation,
and protein synthesis not only for proliferation
but also for diVerentiation, maturation, repair,
and so on.12 Hence, the age related AgNOR
positive proportion of cells may decrease in








*1 8/F 7.37 230 58.7
†2 14/M 4.30 136 62.0
†3 16/M 4.80 34 89.5
†4 17/M 5.40 43 60.0
†5 18/M 5.40 82 78.8
†6 18/M 5.40 89 53.7
*7 22/M 5.73 200 75.0
†8 22/F 4.40 70 68.6
†9 22/M 5.40 111 56.0
*10 24/M 5.80 178 64.6
†11 25/M 5.40 131 56.0
*12 28/F 5.30 640 49.6
*13 29/M 4.97 286 49.1
*14 35/M 5.20 548 35.6
*15 38/F 4.77 254 22.0
*16 40/F 5.80 355 20.0
*17 40/M 5.43 307 56.0
*18 53/M 5.20 368 37.1
Mean (SE) 19.0 (1.3) 5.34 (0.15) 55.1 (3.7)
*Argentinean donor; †Russian donor.
Figure 1 Scatter diagram showing the correlation between
the percentage of AgNOR positive mitoses and aging. There























haemopoietic precursors to compensate/repair
haemopoiesis in relation to insults to the
haemopoietic system without a decrease in the
proliferative activity of erythroid and granulo-
cytic lineages. This would be in agreement with
many clinical findings.27–32
A possible factor that could be very closely
related to bone marrow failure in the elderly is
telomere loss.33–37 It is known that these highly
repeated genetic elements are located at the
ends of all eukaryotic chromosomes.38 They are
necessary for the preservation of genome
stability and cell viability because they prevent
aberrant recombination and degradation of
DNA. During aging, telomere numbers de-
crease significantly because of replication
problems.39 Also, this age related telomere loss
in germ cells, tumour cells, and leukaemic cells
is actively compensated for by a high level of
telomerase activity.40–45 Theoretically, telomer-
ase activity may be associated with both the
level of cellular proliferation and rDNA cistron
activity.46 Therefore, the changes revealed here
in the age related decrease in the proportion of
AgNOR staining on metaphase chromosomes
in bone marrow erythroid and granulocytic
elements may be explained partly by telomere
alterations. Such a hypothesis explains why the
number of AgNOR positive mitoses in bone
marrow samples from patients with mycosis
fungoides13 and acute lymphoblastic leukaemia
(Pedrazzini and Slavutsky, unpublished data)
are not age related. In these diseases, mitoti-
cally active cells are represented by more
immature haemopoietic elements whose telo-
merase activity is higher than maturating
erythroid and granulocytic progenitors. Future
investigations should show whether or not the
hypothesis is correct.
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